Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been assigned a €95.60 ($112.47) price objective by Berenberg Bank in a research note issued to investors on Thursday. The firm currently has a “buy” rating on the stock.

FME has been the subject of a number of other research reports. Citigroup Inc. set a €92.00 ($108.24) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a report on Tuesday, August 8th. Deutsche Bank AG set a €85.00 ($100.00) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “neutral” rating in a report on Wednesday, August 2nd. Kepler Capital Markets set a €95.00 ($111.76) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Wednesday, August 2nd. Goldman Sachs Group, Inc. (The) set a €98.00 ($115.29) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Monday, July 24th. Finally, Commerzbank Ag set a €88.00 ($103.53) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a “neutral” rating in a report on Tuesday, August 1st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of €89.12 ($104.84).

COPYRIGHT VIOLATION WARNING: “Berenberg Bank Analysts Give Fresenius Medical Care AG & Co. (Pref) (FME) a €95.60 Price Target” was reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/11/02/berenberg-bank-analysts-give-fresenius-medical-care-ag-95-60-price-target.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.